|Articles|October 1, 2012

Retrospective: CleanRooms_Dixon

To view a PDF of this article from the BioPharm International archives, click this link

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content

High Angle Shot of a Working Desk of an Successful Person in Office with Cityscape Window View. | Image credit: © Gorodenkoff - stock.adobe.com

Navigating the Next Wave of Biopharma Manufacturing Innovation

ByMike Hennessy Jr.

December 9th 2025

Image Credit: ©Teeraphon; navintar – Stock.Adobe.com

How Mitigation and Maintenance Protect Against Future Risk

BySusan Haigney

December 8th 2025

Creative image of embryonic stem cells, cellular therapy. 3d illustration | Image credit: © pinkeyes - © pinkeyes - stock.adobe.co

Implementing Automation and Flexible Design for Allogeneic Manufacturing

ByJennifer Markarian

December 2nd 2025

A man in protective clothing with test tubes in his hands against the background of a laboratory bioreactor.Experiments in the field of Microbiology. Pharmaceutical research.Synthesis of new chemicals | Image credit: © Grispb - © Grispb - stock.adobe.com

Rentschler–Coriolis Partnership Reflects Demand for Connected Biopharma Workflows

ByFeliza Mirasol

December 2nd 2025

Ampoules vaccine from coronavirus with syringe 3d render illustration on white. | © mylisa - © mylisa - stock.adobe.com

Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths

ByFeliza Mirasol

December 1st 2025

Retrospective: CleanRooms_Dixon

Newsletter

Related Content

Navigating the Next Wave of Biopharma Manufacturing Innovation

How Mitigation and Maintenance Protect Against Future Risk

Implementing Automation and Flexible Design for Allogeneic Manufacturing

Rentschler–Coriolis Partnership Reflects Demand for Connected Biopharma Workflows

Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths

Trending on BioPharm International

Roche Drives Industry Shift With Three-Year Lymphoma Survival Data

FAQ: Milestones You May Have Missed in the 2025 Biopharma Pipeline

How Mitigation and Maintenance Protect Against Future Risk

Navigating the Next Wave of Biopharma Manufacturing Innovation

mRNA development with quantitative expression analysis